Skip to content

Clinical trials

Phase 3 Anemia trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia Phase: Phase 3 Country / region: Bulgaria Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20073
20093
20111
20131
20145
20151
20164
20171
20201
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting3
Terminated2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Akebia Therapeutics3
Amgen3
Astellas Pharma Europe B.V.3
Takeda3
Affymax2
AstraZeneca2
GlaxoSmithKline2
Sandoz2
Janssen Research & Development, LLC1
Janssen-Cilag International NV1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia25
Renal Insufficiency, Chronic14
Kidney Failure, Chronic4
Bone Marrow Diseases3
Myelodysplastic Syndromes3
Primary Myelofibrosis3
Renal Insufficiency3
Hematologic Diseases2
Myeloproliferative Disorders2
Aspergillosis, Allergic Bronchopulmonary1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.